过去一年中添加的文章，按日期排序
Evaluating generalizability of landmark randomized controlled trials in common metastatic cancers using machine learning-based emulated trials.
115 天前 - … the most prevalent advanced cancers – non-small cell lung (… In Stage II, trial emulation,
pts meeting RCT cancer and … (osimertinib) vs control (gefitinib or erlotinib) was 18.9 mos …
pts meeting RCT cancer and … (osimertinib) vs control (gefitinib or erlotinib) was 18.9 mos …
[HTML][HTML] Improving patient selection through tumor genomic recharacterization to overcome resistance to targeted therapy: commentary on the final analysis of the …
299 天前 - … of advanced non-small cell lung cancer (NSCLC) harboring activating EGFR
mutations (1,… -cohort, phase 2 study evaluating the activity of capmatinib in patients with NSCLC …
mutations (1,… -cohort, phase 2 study evaluating the activity of capmatinib in patients with NSCLC …